What is the therapeutic effect of Pramipexole Hydrochloride/Pramipexole Tablets?

Pramipexole hydrochloride (Pramipexole) has significant effects in the treatment of Parkinson's disease (PD) and restless legs syndrome.

Pramipexole immediate-release tablets have been evaluated in five major studies for Parkinson's disease. Four studies compared pramipexole with placebo, and one study compared pramipexole with levodopa. Among them, a study on 360 advanced patients who had already taken levodopa but whose efficacy began to decrease showed that after using pramipexole, the patients' Parkinson's disease symptoms improved significantly during 24 weeks of stable dose treatment. Compared with patients taking placebo, the improvement effect of the pramipexole group was more significant. In addition, three other studies on 886 early-stage patients who did not receive levodopa treatment also confirmed that pramipexole can effectively reduce the severity of the disease, especially after four weeks and 24 weeks, the patients' motor symptoms were greater.

It is worth mentioning that a comparative study between pramipexole and levodopa pointed out that pramipexole showed a better effect in improving the motor symptoms of early Parkinson's disease. This further supports its potential for use in patients at different stages. Additional research shows that both extended-release and immediate-release tablets can be used safely and effectively to treat Parkinson's disease. Although a few patients may need to adjust their dose when switching from immediate-release tablets to extended-release tablets, the overall switching process is safe.

In studies on restless legs syndrome, pramipexole immediate-release tablets have also shown good efficacy. The first 12-week study compared pramipexole to placebo and showed that pramipexole significantly reduced patients' symptoms. In another study, patients who continued to use pramipexole were compared with patients who switched to placebo. Although the long-term effectiveness of pramipexole needs further verification, the short-term effect is obvious.

In summary, pramipexole hydrochloride is an effective therapeutic drug. Its application in Parkinson's disease and restless legs syndrome has been fully supported by clinical research, and it can effectively improve patients' motor symptoms and quality of life. However, appropriate dosage adjustments should be made during treatment according to individual patient conditions to ensure optimal efficacy and safety.

Reference materials:https://en.wikipedia.org/wiki/Pramipexole